BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 10413512)

  • 1. Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease.
    Liu ST; Howlett G; Barrow CJ
    Biochemistry; 1999 Jul; 38(29):9373-8. PubMed ID: 10413512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc binding to Alzheimer's Abeta(1-16) peptide results in stable soluble complex.
    Kozin SA; Zirah S; Rebuffat S; Hoa GH; Debey P
    Biochem Biophys Res Commun; 2001 Jul; 285(4):959-64. PubMed ID: 11467845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer.
    Faller P
    Chembiochem; 2009 Dec; 10(18):2837-45. PubMed ID: 19877000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease.
    Mekmouche Y; Coppel Y; Hochgräfe K; Guilloreau L; Talmard C; Mazarguil H; Faller P
    Chembiochem; 2005 Sep; 6(9):1663-71. PubMed ID: 16078307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of copper(II) on zinc(II)-induced aggregation of amyloid beta-peptide.
    Suzuki K; Miura T; Takeuchi H
    Biochem Biophys Res Commun; 2001 Jul; 285(4):991-6. PubMed ID: 11467850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.
    Danielsson J; Pierattelli R; Banci L; Gräslund A
    FEBS J; 2007 Jan; 274(1):46-59. PubMed ID: 17222176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide.
    Han D; Wang H; Yang P
    Biometals; 2008 Apr; 21(2):189-96. PubMed ID: 17629774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.
    Faller P; Hureau C
    Dalton Trans; 2009 Feb; (7):1080-94. PubMed ID: 19322475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Abeta conformation on the metal affinity and aggregation mechanism studied by circular dichroism spectroscopy.
    Chen YR; Huang HB; Chyan CL; Shiao MS; Lin TH; Chen YC
    J Biochem; 2006 Apr; 139(4):733-40. PubMed ID: 16672274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc binding to amyloid-beta: isothermal titration calorimetry and Zn competition experiments with Zn sensors.
    Talmard C; Bouzan A; Faller P
    Biochemistry; 2007 Nov; 46(47):13658-66. PubMed ID: 17983245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
    Mancino AM; Hindo SS; Kochi A; Lim MH
    Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
    Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
    J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
    Kirkitadze MD; Condron MM; Teplow DB
    J Mol Biol; 2001 Oct; 312(5):1103-19. PubMed ID: 11580253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper catalyzed oxidation of Alzheimer Abeta.
    Atwood CS; Huang X; Khatri A; Scarpa RC; Kim YS; Moir RD; Tanzi RE; Roher AE; Bush AI
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):777-83. PubMed ID: 10875439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-beta peptide disruption of lipid membranes and the effect of metal ions.
    Lau TL; Ambroggio EE; Tew DJ; Cappai R; Masters CL; Fidelio GD; Barnham KJ; Separovic F
    J Mol Biol; 2006 Feb; 356(3):759-70. PubMed ID: 16403524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of the Zn2+ binding in the 1-16 region of the amyloid beta peptide involved in Alzheimer's disease.
    Furlan S; La Penna G
    Phys Chem Chem Phys; 2009 Aug; 11(30):6468-81. PubMed ID: 19809679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence that all three histidine residues coordinate to Cu(II) in amyloid-beta1-16.
    Shin BK; Saxena S
    Biochemistry; 2008 Sep; 47(35):9117-23. PubMed ID: 18690709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations of the molecular mechanism of metal-induced Abeta (1-40) amyloidogenesis.
    Lim KH; Kim YK; Chang YT
    Biochemistry; 2007 Nov; 46(47):13523-32. PubMed ID: 17973493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.